BLD-2660

N/A

Report date: 2024/10/24 17:11:35
NME

Base Information

Drug NameBLD-2660
Drug Alias NameBLD-2660
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalpain1/2 inhibitorsCAPN9 inhibitors
TargetsCalpain1/2CAPN9
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)FibrosisIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBlade Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlade Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsFibrosisIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A